alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Soil and Water Management Research: Bushland, TX
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        


                    CPRL
                        CPRL Home
                                    Livestock Nutrient Management Research UnitSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Plains Area Bushland, Texas Conservation and Production Research Laboratory Soil and Water Management Research Research





- ARS National Programs
- Search for a scientific manuscript
- Search for a research project
- ARS Software
- Programs and Projects
- Collaborations
- Subjects of Investigation
- Publications

Collaborations The Soil and Water Management Research has a long and productive history of collaborative research involving stakeholders.  Current collaborators and projects:


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Resource Related Research Projects (R24 Clinical Trial Not Allowed).                    

*Date:*                         September 22, 2021.                    

*Time:*                         11:00 a.m. to 2:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G41B Rockville, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Zhuqing (Charlie) Li, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G41B, Rockville, MD  20852, (240) 669-5068,                         *zhuqing.li@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: August 23, 2021. 

Tyeshia M. Roberson-Curtis,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2021-18492 Filed 8-26-21; 8:45 am]

BILLING CODE 4140-01-P
#### STEARNS, Appellant, v. TEW, Respondent.

(Supreme Court, General Term, Fifth Department.

December 28, 1895.)

Action by Frank M. Stearns against Harvey W. Tew.

No opinion. Judgment affirmed, with costs. WARD, J., not sitting.
EXHIBIT 32.1
------------



                CERTIFICATIONS PURSUANT TO SECTION 906
                   OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the Annual Report of Landauer, Inc. (the
"Company") on Form 10-K for the fiscal year ended September 30, 2003 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Brent A. Latta, Chief Executive Officer of the Company,
certify that:

     i.    The Report fully complies with the requirements of
           Section 13(a) or 15(d) of the Securities Exchange Act of
           1934; and

     ii.   The information contained in the Report fairly presents, in all
           material respects, the financial condition and results of
           operations of the Company.




                                  /s/ Brent A. Latta
                                  -----------------------------------
                                  President & Chief Executive Officer




December 19, 2003
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONSOLIDATED
STATEMENTS OF INCOME AND CONSOLIDATED BALANCE SHEETS.
</LEGEND>
<RESTATED>
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                              34
<SECURITIES>                                         0
<RECEIVABLES>                                      869
<ALLOWANCES>                                         0<F1>
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 1,372
<PP&E>                                           5,731
<DEPRECIATION>                                       0<F1>
<TOTAL-ASSETS>                                   8,719
<CURRENT-LIABILITIES>                            2,927
<BONDS>                                          1,520
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        300
<COMMON>                                             0
<OTHER-SE>                                       1,914
<TOTAL-LIABILITY-AND-EQUITY>                     8,719
<SALES>                                              0
<TOTAL-REVENUES>                                 2,032
<CGS>                                                0
<TOTAL-COSTS>                                    1,928
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  41
<INCOME-PRETAX>                                     94
<INCOME-TAX>                                        30
<INCOME-CONTINUING>                                 64
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                           13
<NET-INCOME>                                        51
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0
<FN>
<F1>Not separately identified in the consolidated financial statements or
accompanying notes thereto.
</FN>


</TABLE>
* The Honorable John F. Forster, Jr., Untied States Magistrate Judge for the

Eastern District of Arkansas, to whom the case was referred for final disposition by consent of the parties under 28 U.S.C. § 636(c).



## United States Court of Appeals FOR THE EIGHTH CIRCUIT

___________ No. 01-1383

___________ Randy Davis, on behalf of * James F. Davis, Deceased, * * Appellant, * Appeal from the United States

* District Court for the Eastern v. * District of Arkansas. * Larry G. Massanari, Acting * [UNPUBLISHED] Commissioner of Social Security, * * Appellee. *

___________ Submitted: September 5, 2001 Filed: September 11, 2001

___________ Before HANSEN, FAGG, and BEAM, Circuit Judges.

___________ PER CURIAM. Randy Davis appeals the district court's * refusal to consider new evidence in affirming the Commissioner's denial of disability insurance benefits and supplemental security income. Having carefully considered the record and the parties' submissions-2-

onappeal, we agree with the district court that the evidence was not material. See Jones v. Callahan , 122 F.3d 1148, 1154 (8th Cir. 1997) (new evidence must pertain to timeperiod for which benefits are sought, and not concern later-acquired disabilities or later deterioration of an earlier non-disabling condition). Thus, we do not reach Davis's contention that the district court misapplied the standard for determining when alcohol use disqualifies a claimant. We affirm the judgment of the district court. See 8th Cir. R. 47B. A true copy. Attest: CLERK, U.S. COURT OF APPEALS, EIGHTH CIRCUIT.
II

105TH CONGRESS

2D SESSION S. 1847

To suspend temporarily the duty on streptomycin sulfate.

IN THE SENATE OF THE UNITED STATES

MARCH 24, 1998

Mr. HELMS introduced the following bill; which was read twice and referred

to the Committee on Finance

A BILL

To suspend temporarily the duty on streptomycin sulfate.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. STREPTOMYCIN SULFATE.

4 (a) IN GENERAL.—Subchapter II of chapter 99 of

5 the Harmonized Tariff Schedule of the United States is

6 amended by inserting in numerical sequence the following

7 new heading:

‘‘ 9902.29.44 Streptomycin sulfate (CAS

No. 57–92–1) (provided for

in subheading 2941.20.50) ... Free No change No change On or before

12/31/02 ’’.

8 (b) EFFECTIVE DATE.—The amendment made by

9 subsection (a) applies with respect to articles entered, or
2

•S 1847 IS

1 withdrawn from warehouse for consumption, on or after

2 the 15th day after the date of enactment of this Act.

Æ
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Invasive Plant Research Laboratory: Fort Lauderdale, FL
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        


                    Outreach
                        Volunteer
                                    Outreach Activities 2019
                                    Outreach Activities 2020
                                    Outreach Activities 2022
                    K.I.N.D. GardenSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Southeast Area Fort Lauderdale, Florida Invasive Plant Research Laboratory People & Locations







Lexa  Greenley
                        Invasive Plant Research Laboratory

                        




                        
                        Administrative Officer
                        Phone: (954) 475-6541
                        
                        
                        Fax: (954) 476-9169(Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
<PAGE>



                                  UNITED STATES
                         SECURITIES EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-Q/A

                     --------------------------------------

           [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2000

                     --------------------------------------

                           5B TECHNOLOGIES CORPORATION
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)


                 DELAWARE                                 11-3529387
                 --------                                 ----------
          STATE OF INCORPORATION                      IRS EMPLOYER ID NO.


                100 SUNNYSIDE BOULEVARD, WOODBURY, NEW YORK 11797
                -------------------------------------------------
                    (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES )

                  REGISTRANT'S TELEPHONE NUMBER (516) 677-6100

Check here whether the issuer (1) has filed all reports required to be filed by
Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past
90 days. Yes  X  No
             ---    ---


     As of December 8, 2000, the following shares of the Registrant's common
                       stock were issued and outstanding:




               Common Stock, $0.04 par value per share 2,140,532


<PAGE>

Explanatory Note:

5B Technologies Corporation, pursuant to Rule 12b-15 under the Securities
Exchange Act of 1934, is hereby filing, under the cover of Form 10-Q/A,
Amendment No. 1, an explanatory note in order to correct a typographical error
contained in the Consolidated Balance Sheet for the nine months ended September
30, 2000. Specifically, the total stockholders' equity for the nine months ended
September 30, 2000 should be "5,272,623"and not "5,27,623" as filed previously.

The foregoing correction to the Consolidated Balance Sheet for the nine months
ended September 30, 2000 does not have any impact on reported earnings or
earnings per share for any periods presented.


<PAGE>



      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                  5B TECHNOLOGIES CORPORATION


Date: December 11, 2000           By: /s/  Anthony Fernandez
                                      -----------------------
                                      Anthony Fernandez, V.P. of Finance
EXHIBIT 14

ITRONICS INC.

CODE OF BUSINESS CONDUCT AND ETHICS

 

March 25, 2004

The Board of Directors of Itronics Inc. has adopted the following Codeof Business Conduct and Ethics (the Code). This Code is applicable to all directors,officers, and other senior management personnel (Management) of Itronics Inc. and itssubsidiaries. The purpose of this Code is to promote the highest standards of ethicalconduct of business.

> 
Management will practice honesty, integrity and good faith in every    aspect of dealing with other Company personnel, shareholders, the public, customers,    suppliers and government authorities. All persons are to be treated with dignity and    respect.

Management will respect and obey all applicable federal, state, and    local laws and regulations. Management will not only follow the letter of the law, but the    spirit as well. 

Management will do its utmost to avoid real or perceived conflicts of    interest in our business dealings. Apparent conflicts of interest are to be disclosed to    the appropriate person promptly. 

Management will prepare reports and other disclosures to be    disseminated to the public or to be filed with the Securities and Exchange Commission or    other governmental authorities in a full, fair, accurate, timely, and understandable    manner. The needs of our investors and the investing public will always be the foremost    priority in preparing such reports or disclosures.

Trading of the Company’s securities will be conducted under all    applicable laws and rules of the Securities and Exchange Commission. Management will not    take unfair advantage of any publicly undisclosed information it may have regarding the    operations of the Company and its subsidiaries. 

Each member of Management is responsible to conduct him or herself in    accordance with this Code. Any observed violations are to be reported to the appropriate    person promptly. Violations of this Code subject the individual to disciplinary action and    possible termination.

Management includes directors, the principal executive officer, the    principal accounting officer or controller, or employees performing similar functions. 

 

The appropriate person to discuss any questions about this Code,  observed violations of the Code, or potential conflicts of interest is the principal  executive officer, which is currently the President of the Company. 

84

----
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Crop Diseases, Pests and Genetics Research: Parlier, CA
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        


                    Research Units
                        San Joaquin Valley Agricultural Sciences Center
                                    Commodity Protection and Quality Research
                                    Water Management Research
                                    National Arid Land Plant Genetic RepositorySearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Pacific West Area Parlier, California San Joaquin Valley Agricultural Sciences Center Crop Diseases, Pests and Genetics Research People & Locations







Baudelio  Perez
                        Crop Diseases, Pests and Genetics Research

                        




                        
                        Biological Science Technician
                        Phone: (559) 596-2807
                        
                        
                        Fax: (Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov